CEDRUS’s Thermo Fisher Scientific TMO Stock Holding History

CEDRUS’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$386K	Buy	624 +152	+32%	+$90K	0.14%	119
2024 Q2	$261K	Sell	472 -43	-8%	-$24.6K	0.13%	135
2024 Q1	$299K	Sell	515 -29	-5%	-$16.3K	0.16%	118
2023 Q4	$289K	Sell	544 -35	-6%	-$16.9K	0.18%	122
2023 Q3	$293K	Sell	579 -106	-15%	-$56.5K	0.21%	110
2023 Q2	$357K	Sell	685 -16	-2%	-$8.63K	0.25%	89
2023 Q1	$404K	Sell	701 -19	-3%	-$10.7K	0.28%	74
2022 Q4	$396K	Sell	720 -14	-2%	-$7.42K	0.32%	67
2022 Q3	$372K	Buy	734 +56	+8%	+$31.3K	0.35%	56
2022 Q2	$368K	Buy	678 +26	+4%	+$14.3K	0.36%	54
2022 Q1	$385K	Buy	652 +77	+13%	+$44.2K	0.35%	68
2021 Q4	$384K	Buy	+575	New	+$359K	0.37%	80

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CEDRUS's TMO Position: Q3 2024 in Review

CEDRUS increased its Thermo Fisher Scientific (TMO) stake by 32% in Q3 2024, buying an estimated $90K and bringing the position to 624 shares worth $386K. The position accounts for 0.14% of the portfolio, ranked #119.

CEDRUS first reported a position in TMO in Q4 2021 and has held it in 12 quarters since. The position peaked at $404K in Q1 2023. 2,570 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

CEDRUS held 624 shares of Thermo Fisher Scientific worth $386K as of Q3 2024.
CEDRUS bought 152 Thermo Fisher Scientific shares in Q3 2024, an estimated $90K.
Thermo Fisher Scientific made up 0.14% of CEDRUS's portfolio in Q3 2024, its #119 holding.
CEDRUS first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 12 quarters since.
CEDRUS's Thermo Fisher Scientific position peaked at $404K in Q1 2023.
2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on CEDRUS's 13F filing for Q3 2024, filed 18 Oct 2024.